ITGAX and graft versus host disease: Mice with cGvHD harbored significantly more activated myeloid (CD11b+CD11c+) and lymphoid (CD11b-CD11c+) DCs and myeloid NK cells (CD11b+CD11c-) than control mice especially at GvHD onset.